Literature DB >> 3677357

Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone.

H Drexler1, F Faude, S Höing, H Just.   

Abstract

Recent studies suggest that, in the presence of heart failure, the capability of skeletal muscle to utilize delivered flow may be impaired due to maldistribution of blood flow within working muscle. Similarly, this mechanism could explain the failure of drugs to improve maximal oxygen consumption (VO2max) immediately. Accordingly, we assessed muscular blood flow distribution (ml/min/g, radioactive microspheres, 15 +/- 5 micron) among and within working muscle, VO2max, and arterial lactate in a rat preparation of myocardial infarction and heart failure (infarct size 36.0 +/- 3.3% of the left ventricle, n = 9), and in sham-operated animals (n = 11). Data were obtained at maximal treadmill exercise during alternate infusions of milrinone and saline. Total skeletal muscle blood flow during exercise was significantly lower in the infarction group (p less than .05 vs sham); reduced blood flow was primarily attributed to decreased flow to oxidative working muscle such as soleus and the red portion of gastrocnemius, whereas blood flow to glycolytic muscle portions (e.g., gastrocnemius white, vastus lateralis white) was similar in the infarction and sham-operated groups. Milrinone increased flow to the glycolytic working muscle portions in sham-operated animals (e.g., vastus lateralis white, 0.23 vs 0.29, p less than .05); by contrast, blood flow to the oxidative muscle fibers was increased in the infarction group (e.g., gastrocnemius red, 1.45 vs 1.87, p less than .05). Arterial lactate levels at similar workloads during exercise were higher in the infarction group (p less than .05). Neither lactate nor VO2max were significantly altered with milrinone in either group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677357     DOI: 10.1161/01.cir.76.6.1344

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Skeletal muscle glycogen depletion during submaximal exercise in rats with chronic heart failure.

Authors:  T I Musch; M R Ghaul; V Tranchitella; R Zelis
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

2.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Authors:  Bishnu P Dhakal; Rajeev Malhotra; Ryan M Murphy; Paul P Pappagianopoulos; Aaron L Baggish; Rory B Weiner; Nicholas E Houstis; Aaron S Eisman; Stacyann S Hough; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2014-10-24       Impact factor: 8.790

Review 3.  Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.

Authors:  David C Poole; Daniel M Hirai; Steven W Copp; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

Review 4.  The treatment of heart failure--what next?

Authors:  R H Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 5.  Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.

Authors:  H Drexler
Journal:  Br Heart J       Date:  1994-09

Review 6.  Peripheral circulatory adaptations to pump failure of the heart.

Authors:  H Drexler
Journal:  Br Heart J       Date:  1994-08

7.  Neuronal nitric oxide synthase regulation of skeletal muscle functional hyperemia: exercise training and moderate compensated heart failure.

Authors:  Daniel M Hirai; Steven W Copp; Scott K Ferguson; Clark T Holdsworth; K Sue Hageman; David C Poole; Timothy I Musch
Journal:  Nitric Oxide       Date:  2017-12-27       Impact factor: 4.427

Review 8.  Central mechanisms for exercise training-induced reduction in sympatho-excitation in chronic heart failure.

Authors:  Karla K V Haack; Irving H Zucker
Journal:  Auton Neurosci       Date:  2014-10-18       Impact factor: 3.145

Review 9.  Milrinone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  R A Young; A Ward
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

10.  Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.

Authors:  Gregory D Lewis; Marc J Semigran; Michael M Givertz; Rajeev Malhotra; Kevin J Anstrom; Adrian F Hernandez; Monica R Shah; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.